<?xml version="1.0" encoding="UTF-8"?>
<p>Hepatectomy is an effective and safe therapy for hepatic tumors (
 <xref rid="B4" ref-type="bibr">4</xref>–
 <xref rid="B6" ref-type="bibr">6</xref>). Previous studies have found that ERAS strategy was beneficial to patients receiving hepatectomy (
 <xref rid="B7" ref-type="bibr">7</xref>–
 <xref rid="B9" ref-type="bibr">9</xref>). However, limited studies have assessed the ERAS strategy in patients receiving hepatectomy in China. More importantly, there is nearly no studies comparing the clinical outcomes of patients receiving hepatectomy with or without ERAS strategy all over the world. For the first time in China, the current study was designed to compare the clinical outcomes between Chinese patients receiving hepatectomy with or without ERAS strategy.
</p>
